Youping Li

Title: Innovations in Tumor Immunotherapy by Youping Li

Introduction

Youping Li is a prominent inventor based in Hubei, China. He has made significant contributions to the field of tumor immunotherapy, focusing on the development of innovative polypeptides for cancer treatment. His work aims to enhance the effectiveness of immunotherapy in combating tumors.

Latest Patents

Youping Li holds a patent for a "Tumor immunotherapy polypeptide and application thereof." This patent provides a polypeptide designed for tumor immunotherapy, which includes at least one polypeptide from a first peptide group and optionally, at least one from a second peptide group. The first peptide group comprises polypeptides with specific amino acid sequences, while the second group includes additional polypeptides. The patent also covers various applications, including isolated nucleic acids, constructs, expression vectors, and methods for treating patients suffering from tumors. He has 1 patent in total.

Career Highlights

Youping Li is associated with Genoimmune Therapeutics Co., Ltd., where he continues to advance research in immunotherapy. His work is pivotal in developing new therapeutic strategies for cancer treatment, showcasing his commitment to improving patient outcomes.

Collaborations

Youping Li collaborates with notable colleagues, including Le Zhang and Si Qiu. Their combined expertise contributes to the innovative research and development efforts at Genoimmune Therapeutics Co., Ltd.

Conclusion

Youping Li's contributions to tumor immunotherapy represent a significant advancement in cancer treatment. His innovative polypeptide patent highlights the potential for new therapeutic approaches in combating tumors.